Nuclear DNA content, proliferative activity, and p53 expression related to clinical and histopathologic features in endometrial carcinoma
- 1 January 2002
- journal article
- Published by Elsevier in International Journal of Gynecologic Cancer
- Vol. 12 (1) , 110-118
- https://doi.org/10.1046/j.1525-1438.2002.01079.x
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- MIB-1 in Endometrial Carcinoma: Prognostic Significance with 5-Year Follow-UpGynecologic Oncology, 1999
- Prognostic Significance of Angiogenesis and Ki-67, p53, and p21 Expression: A Population-Based Endometrial Carcinoma StudyJournal of Clinical Oncology, 1999
- A comparison of proliferation markers and their prognostic value for women with endometrial carcinoma: Ki-67, proliferating cell nuclear antigen, and flow cytometric S-phase fractionCancer, 1996
- Mutant p53 protein as a predictor of survival in endometrial carcinomaEuropean Journal Of Cancer, 1996
- Expression of MIB-1 (Paraffin ki-67) and AgNOR Morphology in Endometrial Adenocarcinomas of Endometrioid TypeInternational Journal of Gynecological Pathology, 1994
- Letters to the editorThe Journal of Pathology, 1992
- Comparison between flow cytometry and image cytometry in ploidy distribution assessments in gynecologic cancerCytometry, 1992
- The prognostic significance of DNA measurements in endometrial carcinomaCytometry, 1984
- Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferationInternational Journal of Cancer, 1983
- Monoclonal Antibody to 5-Bromo- and 5-Iododeoxyuridine: A New Reagent for Detection of DNA ReplicationScience, 1982